5 min read
Measure Twice, Cut Once: The Value of Target Analysis in Antibody Discovery
By Joshua Lowitz on Jan 12, 2021 1:10:12 PM
Editor’s note: Welcome to 2021, and to our first in a year-long series of posts that will explore the essentials in antibody discovery. We’re starting off with a frequently under-appreciated technique for getting to “yes” or “no” faster — target analysis. Next up, in early February, we’ll be talking about fusions. Thanks for reading, and we invite your ideas on what you consider to be “the essentials” of antibody research success.
Topics: Insights Therapeutic Targets Target Analysis Immunogens
Filter by Keyword
- Insights (33)
- Events (16)
- COVID-19 (15)
- Covid (14)
- SARS-CoV-2 (14)
- News (10)
- Molecular Modeling (9)
- Transgenic Animals (6)
- Antibody Discovery (4)
- Therapeutic Targets (3)
- 25th Anniversary (2)
- Omicron (2)
- Therapeutic Monoclonal Antibodies (2)
- Antibody Generation (1)
- Antibody-Drug Conjugate (ADC) (1)
- Antigen (1)
- CAR-T (1)
- Cell Fusion (1)
- Cell therapy (1)
- Functional Assays (1)
- Harbour (1)
- Hybridoma (1)
- IgG purification (1)
- Immunoassays (1)
- Immunogens (1)
- Lambda Light Chain (1)
- Lambda Mouse (1)
- MAbExpress (1)
- Monoclonal (1)
- OmniRat (1)
- Peptides (1)
- Syngeneic (1)
- Target Analysis (1)
- Transgenic H2L2 Mice (1)
- Women In Bio (1)
- igG (1)
- mRNA (1)